CION Ameerpet
Kidney cancer · Treatment & modalities
Ablation for kidney tumours — destroying a small tumour without removing it
Someone has raised ablation for your kidney tumour — radiofrequency ablation (RFA) or cryoablation — and it sounds almost too easy: a needle instead of an operation, home the same day or the next. The idea is genuinely that simple. A probe is passed through the skin into the tumour under scan guidance and the tumour is destroyed where it sits, by heat or by freezing, with no incision and no kidney removed. What takes longer to explain is the trade-off. Because nothing is taken out, there is no specimen and no margin to examine, so the proof that it worked comes from scans over the following years rather than from a pathology report. That trade-off is worth making for some people and not for others, and this page is about telling those two situations apart.
- A needle, not an incision — an interventional radiologist places the probe under CT or ultrasound guidance, usually under sedation or a general anaesthetic, with observation for hours rather than days.
- Heat or cold, same principle — RFA cooks the tumour and a rim around it; cryoablation freezes and thaws it in cycles. Both leave the kidney in place.
- Chiefly for small tumours — generally under 4cm and sitting towards the outside of the kidney. NCCN guidance weighs it alongside surgery and active surveillance, not as a last resort.
- Coordinated, not in-house — ablation is performed and billed at a specialist partner centre; CION arranges it with interventional radiology and uro-oncology and leads everything around it.
17+
Cancer Specialists
on Panel
on Panel
35+
Centres across
Telangana & AP
Telangana & AP
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Read this first
What kidney tumour ablation actually is
Ablation destroys the tumour. It does not take it out. Everything that is different about this treatment follows from that one sentence. You lie on a CT or ultrasound table rather than an operating table, usually under sedation or a general anaesthetic. An interventional radiologist steers one or more needle-thin probes through the skin of your back or side, watching the scan as they go, until the tip sits inside the tumour. Energy is then delivered through the probe until the tumour and a small rim of tissue around it are dead. The probes come out, a dressing goes over the puncture site, and the kidney stays exactly where it was.
Heat or cold — two ways of doing the same job. Radiofrequency ablation, usually shortened to RFA, passes an electrical current through the probe tip; the tissue immediately around it heats up and is destroyed. Cryoablation works the other way, cooling the probe far below freezing so that the tumour is frozen and thawed in cycles until its cells rupture. One useful practical difference is that the ice ball cryoablation creates can be seen on the scan as it forms, so the radiologist can watch the treated zone growing and stop it short of anything that must be protected. Heat-based ablation is often quicker and may need fewer probes. Neither is the advanced option and neither is the budget option; they are two tools, chosen on the anatomy in front of the radiologist.
It is a small-tumour treatment. Ablation is used mainly for small renal masses — tumours under about 4cm, and it works best when the tumour bulges outwards from the surface of the kidney rather than sitting deep in the middle. NCCN guidance treats ablation as one of the options for a small renal mass, weighed against surgery and against a period of watching, rather than as something offered only when everything else has been ruled out. It comes into its own when an operation would be a bigger risk than the tumour: an older patient, significant heart or lung disease, poor kidney function, one working kidney, or an inherited condition that will keep producing new tumours over a lifetime and makes every kidney-sparing decision count.
What it cannot give you is a pathology report on the whole tumour. Surgery hands the pathologist the tumour with a margin around it, so the questions of what it was and whether all of it came out are answered on paper. Ablation leaves the tissue inside you, so those answers come instead from a needle biopsy taken before or during the procedure, and from contrast scans over the following years that ask a single question: is any part of the treated area still taking up contrast? That is why the biopsy beforehand matters more here than it does before an operation — and why, given that up to a third of small kidney masses turn out to be benign, being sure what you are treating is not a formality. For very small, slow-looking tumours the honest third option is neither treatment: active surveillance is a legitimate plan rather than a way of doing nothing.
And where it is done matters to you practically. Ablation is not delivered in-house at CION. Nor is kidney surgery of any kind — partial, radical, laparoscopic, open, robotic or cytoreductive nephrectomy — nor PET-CT. All of those are carried out at specialist partner centres, where they may also be billed, and CION coordinates them with specialist interventional radiology, urology and uro-oncology teams. What CION leads in-house is the rest of the pathway: the consultation, the CT, ultrasound and MRI, the biopsy, the blood and kidney-function tests, the tumour board that decides whether ablation is right for you at all, the surveillance scans afterwards, and any systemic treatment or radiation that follows.
This page covers one treatment option in detail. For the whole picture — types, stages, kidney-sparing surgery and living with one kidney — see our kidney cancer guide, or kidney cancer treatment in Hyderabad for how the options sit together. If ablation has been suggested and you are not sure it is the right call, book a free consultation and go through the scans first.
Did you know?
After a successful ablation the tumour does not disappear from your scans. The treated tissue stays in the kidney, slowly shrinking and scarring, so a nodule will still be visible at the site for years. What the radiologist actually looks for is enhancement — whether the area still takes up contrast — because that, not the presence of a lump, is what signals living tumour tissue. Knowing this in advance saves a great deal of unnecessary fear at your first follow-up scan.
Two probes, and the alternatives
RFA, cryoablation and what they are weighed against
Read the first two rows as two tools rather than as a ranking, and the last three as the honest company ablation keeps. For a small kidney tumour there is rarely one obvious answer, which is why the decision belongs to a tumour board rather than to whoever you happen to see first.
| Option | What happens | Where it tends to fit |
|---|---|---|
| RFA (heat) | An electrical current through the probe tip heats and destroys the tumour and a small rim of tissue around it, in one or more cycles. | Small tumours towards the outside of the kidney, with a margin of fat around them. Often quicker and may need fewer probes than freezing. |
| Cryoablation (cold) | The probe is cooled far below freezing; the tumour is frozen and thawed in cycles, forming an ice ball that is visible on the scan as it grows. | Where the treated zone needs to be watched precisely as it forms — for instance a tumour lying near a structure that must be kept out of the way. |
| Surgical removal | The tumour, or the whole kidney, is removed in theatre and sent to pathology, giving a definitive answer on type, grade and margin. | Larger or centrally placed tumours, anything where the diagnosis or the margin must be certain, and generally where a person is fit for an operation. |
| Active surveillance | No treatment yet. The tumour is measured on a scan schedule, and intervention is triggered only by meaningful growth or a change in its behaviour. | Very small tumours, particularly in older patients or where other illnesses make any procedure a real risk. A plan, not a refusal to treat. |
| The same whichever is chosen | The decision rests on the size and position of the tumour, on how well both kidneys work, and on your general health — not on preference. | This row is the point of the table. There is no universally best option for a small renal mass; there is only the one that fits your tumour and you. |
Two questions are worth asking out loud before you agree to anything: is my tumour in a position where ablation can reliably treat all of it? and what is the plan if a follow-up scan shows enhancement? A team that can answer both without hesitating is a team that has thought about your case. See how the options are set out together in kidney cancer treatment in Hyderabad.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
A small tumour deserves an unhurried decision
Bring your scans and reports. We will tell you whether your tumour is suited to ablation, what surgery or surveillance would offer instead, and what each would mean for your kidney function. Decisions for healing, not billing.
Where it fits
When ablation is the right choice — and when it is not
Ablation is a genuinely good answer to a narrow question. Most of the disappointment around it comes from stretching it to tumours it was never suited to, so it is worth being clear about both halves.
Strongest case
A small tumour bulging outwards, in someone for whom an operation is a real risk
This is the situation ablation was built for: a tumour under about 4cm, sitting towards the surface of the kidney with a cushion of fat around it, in a person whose age, heart, lungs or other illnesses make a general anaesthetic and an operation the bigger threat. The probe reaches the tumour easily, the treated zone can be extended safely past its edge, and the whole thing is done through a puncture rather than an incision.
Kidney function
One working kidney, or kidney function that is already reduced
When there is less kidney to spare, every millilitre of function you keep counts. Ablation destroys a small volume of tissue around the tumour and leaves the rest untouched, which makes it attractive where chronic kidney disease, diabetes or a single functioning kidney means that losing more tissue could tip you towards dialysis. This is a judgement made on measured kidney function and on what both kidneys look like on the scan, not on the tumour alone.
Inherited disease
An inherited condition that keeps producing new tumours
Some people are not treating one tumour but a lifetime of them. Where an inherited syndrome means new kidney tumours will keep appearing, the guiding principle becomes preserving as much kidney as possible across decades rather than dealing decisively with today's lesion. Ablation can be repeated, and repeated again, in a way that repeated surgery on the same kidney cannot easily be. That long view is exactly the kind of decision a tumour board should be making.
Fits less well
Tumours sitting deep in the middle of the kidney
A tumour close to the hilum, where the blood vessels enter, or hard against the collecting system is a harder target. Large vessels carry heat or cold away and can leave the edge of the tumour under-treated, and the collecting system and the structures around it can be injured. It is not an absolute bar — techniques exist to protect nearby structures — but it shifts the balance, and a radiologist who says your tumour is awkwardly placed is telling you something useful.
Fits less well
Larger tumours, or where certainty about the pathology matters
As a tumour grows, treating every part of it through a probe becomes less reliable, and the case for removing it strengthens. So does the case for surgery when the diagnosis, the grade or a clear margin will change what happens next, because ablation cannot supply a whole-specimen pathology report. A younger, fit person with a straightforward tumour is usually offered surgery for that reason, not because ablation is inferior in principle.
The question to ask
What happens if a follow-up scan shows enhancement?
Ask it before you consent, not afterwards. Tissue that survives an ablation is not a disaster and it is not rare enough to ignore, and the answer you want to hear is a plan: repeat the ablation, or move to surgery, decided by the same board on the same imaging. A team that has already thought about the second step is one that will not leave you improvising if the first scan is not clean.
The referral pathway
How ablation is arranged through CION
Be clear on one thing first, because it affects who treats you and who bills you. Ablation is not delivered in-house at CION. Neither is any nephrectomy — partial, radical, laparoscopic, open, robotic or cytoreductive — nor PET-CT. All of those are carried out at specialist partner centres, where they may also be billed, and CION coordinates them with specialist interventional radiology, urology and uro-oncology teams. What is led in-house is the rest of the pathway, which is most of it.
The tumour board decides whether ablation is the right option at all
Every kidney case at CION goes to a uro-oncology tumour board rather than being settled by one doctor in one clinic. The board works through the imaging and answers the real question first: treat or watch, and if treat, remove or ablate. Only when that is agreed does anyone book a procedure. A recommendation for ablation that has not been through that discussion is worth pausing over.
A biopsy first, because ablation will leave no specimen
An image-guided needle biopsy is usually taken before or at the time of ablation, and this is the step people are most tempted to skip. Once the tumour has been destroyed there may be no tissue left to tell you what it was, and a meaningful share of small kidney masses turn out to be benign. Knowing the answer shapes how closely you are followed and what your family may need to know.
Kidney function and fitness are worked up in-house
Before any kidney treatment the team needs to know how well both kidneys work, not just the affected one, because that is often the argument for ablating rather than removing. Blood and kidney-function tests, review of the CT or MRI, and assessment of your heart, lungs, diabetes and blood pressure are done at CION and travel with you. The expected cost at the partner centre is put in writing before anything is booked.
Referral to interventional radiology at a specialist partner centre
The referral goes out with the imaging, the biopsy result if it is back, and the tumour board's recommendation, so you are not starting from scratch or carrying films between hospitals. The interventional radiologist reviews it independently and may disagree — deciding, for instance, that the tumour's position makes surgery the safer bet. That independent look is the point of the referral, not a hitch in it.
On the day: what actually happens
You are sedated or asleep under a general anaesthetic and positioned, often on your front or side, on the scanner table. The skin is numbed, the probes are advanced into the tumour under scan guidance, and the treatment is delivered in cycles, with images checked as it proceeds. The probes are removed, a dressing is applied, and you are watched for a few hours or overnight. There are no stitches and no drains to manage at home.
Afterwards, the surveillance schedule is the other half of the treatment
Because nothing was removed, the scans are how you and your team know it worked. A contrast scan within the first few months confirms the whole tumour was covered, and imaging continues at agreed intervals after that, with kidney function checked alongside. CION leads that follow-up in-house along NCCN lines, and if enhancement appears the same board decides the next step. Kidney cancer treatment in Hyderabad sets out what each of those steps involves.
You do not have to work this out alone
One appointment usually settles which option your tumour calls for
Many people arrive asking about ablation and leave with something more useful: a clear view of what their scan actually shows and what each option would mean. No rushed decisions. No unnecessary tests.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Kidney tumour ablation — your questions answered
What is the difference between RFA and cryoablation for a kidney tumour?
Both destroy the tumour where it sits, through a needle-thin probe passed into it under scan guidance, and both leave the kidney itself in place. Radiofrequency ablation, usually shortened to RFA, passes an electrical current through the probe tip to generate heat, cooking the tumour and a small rim of tissue around it. Cryoablation does the opposite: the probe is cooled far below freezing and the tumour is frozen and thawed in cycles until the cells rupture. The practical differences are modest. Cryoablation forms an ice ball that can be seen on the scan while the treatment is happening, which helps when the tumour sits close to something that must be protected. Heat-based ablation is often quicker and may need fewer probes. Which is used depends on the size and position of your tumour and on the radiologist's judgement, not on one being better than the other.
Is ablation as good as surgery for a small kidney tumour?
For carefully selected small tumours it is a recognised option, and NCCN guidance places ablation alongside surgery and active surveillance for small renal masses rather than treating it as a last resort. It is not interchangeable with surgery for everyone, though. Surgery removes the tumour and hands the pathologist the whole specimen with a margin to examine, so what it was and whether all of it came out is settled definitively. Ablation destroys the tumour in place, so that reassurance comes from years of follow-up scans instead of from a specimen, and tissue that survives the treatment is somewhat more likely to need a second sitting. Ablation earns its place where avoiding an operation genuinely matters: older age, other serious illnesses, reduced kidney function, one working kidney, or an inherited condition that keeps producing tumours.
Do I need a biopsy before kidney tumour ablation?
Usually yes, and it matters more here than it does before surgery. Ablation destroys the tumour in place, so unless tissue is taken first there may never be a specimen to say what was treated. Up to a third of small kidney masses turn out to be benign, and knowing which yours was changes what follows: how closely you are watched, what your risk of another tumour is, and what your family may need to be told. The biopsy is a needle sample taken under scan guidance, sometimes at the same sitting as the ablation and sometimes a few weeks earlier so that the result is back before anything is decided. Your team will tell you which order they prefer in your case, and why.
Is kidney tumour ablation done at CION, or somewhere else?
Somewhere else, and we would rather say so plainly than let you discover it on the day. Ablation is not delivered in house at CION. Like every kidney operation, partial, radical, laparoscopic, open and robotic nephrectomy included, and like PET-CT, it is carried out at a specialist partner centre where it may also be billed, and CION coordinates it with specialist interventional radiology and urology or uro-oncology teams. What is led in house is everything around the procedure: the consultation, the CT, ultrasound or MRI, the biopsy, the blood and kidney function tests, the tumour board that decides whether ablation is the right choice at all, your surveillance scans afterwards, and any treatment that follows. The expected cost is put in writing before anything is booked.
What does having a kidney tumour ablated involve, and what are the risks?
It is done through the skin rather than through an incision, usually under sedation or a general anaesthetic, with the probe guided into the tumour using CT or ultrasound. Most people are observed for a few hours or overnight rather than staying for days, and there are no stitches to speak of, just a dressing over a puncture site. Soreness over the flank and tiredness for a few days afterwards are normal. The risks are real but uncommon: bleeding around the kidney, injury to a nearby structure such as the bowel or the collecting system, infection, irritation of a nearby nerve, and some loss of kidney function. Which of those matter most depends entirely on where your tumour sits, and the interventional radiologist will go through the ones relevant to you before you consent.
How will I know the ablation worked if the tumour is not removed?
By scanning, on a schedule, for years. The treated tissue stays where it is, so scans will keep showing something at the site, a shrinking and scarring nodule, and its presence is expected rather than a bad sign. What the radiologist looks for instead is enhancement, meaning whether the area still takes up contrast, because that is what indicates living tumour tissue. A scan is usually done within the first few months to confirm the whole tumour was treated, and imaging then continues at intervals your team will set out. If enhancement appears it does not mean the approach failed; tissue that survived can often be ablated again, and surgery remains available. This is exactly why the follow-up schedule after ablation is not optional.
This page is general information about how kidney tumour ablation works and where it fits among the options. It is not a diagnosis and it is not treatment advice for your case. Only a specialist who has reviewed your imaging and examined you can tell you whether ablation, surgery or surveillance is right for you.